| Literature DB >> 32099005 |
Sneha Bansode1, Uliana Bashtanova1, Rui Li1, Jonathan Clark2, Karin H Müller1,3, Anna Puszkarska1, Ieva Goldberga1, Holly H Chetwood1, David G Reid1, Lucy J Colwell1, Jeremy N Skepper3, Catherine M Shanahan4, Georg Schitter5, Patrick Mesquida6,7, Melinda J Duer8.
Abstract
Collagen fibrils are central to the molecular organization of the extracellular matrix (ECM) and to defining the cellular microenvironment. Glycation of collagen fibrils is known to impact on cell adhesion and migration in the context of cancer and in model studies, glycation of collagen molecules has been shown to affect the binding of other ECM components to collagen. Here we use TEM to show that ribose-5-phosphate (R5P) glycation of collagen fibrils - potentially important in the microenvironment of actively dividing cells, such as cancer cells - disrupts the longitudinal ordering of the molecules in collagen fibrils and, using KFM and FLiM, that R5P-glycated collagen fibrils have a more negative surface charge than unglycated fibrils. Altered molecular arrangement can be expected to impact on the accessibility of cell adhesion sites and altered fibril surface charge on the integrity of the extracellular matrix structure surrounding glycated collagen fibrils. Both effects are highly relevant for cell adhesion and migration within the tumour microenvironment.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32099005 PMCID: PMC7042214 DOI: 10.1038/s41598-020-60250-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(A) The consensus sequence for mammalian collagen type I arranged by D period, the expected arrangement in in vivo collagen fibrils[44] showing the distribution of charged residues along the sequence. The collagen molecule consists of three peptide chains, two α1 and one α2 chain, each staggered by one residue with respect to each other and twisted into a triple helix for the majority of their length (stagger not shown because it is unknown whether the heterochain, a2, is in the leading, middle or trailing position within the triple helix). The schematic corresponds to the repeat unit cell in a collagen fibril. This arrangement leads to the so-called overlap zone, where all five D periods overlap and the gap zone where the short D5 period leads to a gap or hole in the fibrillar structure. Note that only the triple helical region of the molecule is shown and that the non-helical N- and C-terminal telopeptide sequences are not shown. The charged amino acids are highlighted in red (negatively charged residues) and blue (positively charged residues). The regions enclosed in rectangular boxes indicate collagen sub-bands as determined by TEM[44]. These regions contain an abundance of charged residues, both positively and negatively charged (note that the schematic does not represent the exact alignment of charges because the chain stagger within the triple helix is not included here and because the triple helix does not have constant pitch over its length). (B) 2D representation of the collagen type I fibril structure determined from x-ray diffraction analysis (3HR2) for one D period with N- and C-terminal telopeptides included[57], showing the spatial distribution of charged residues. Charged residues highlighted as in (A). Note that only Cα atoms are shown and that the spheres representing them are not indicating van der Waals radii.
LC-MS analysis of enzymatic cross links and pre-existing glucose glycation for type I collagen used in this work and ribose-5-phosphate glycated collagen per mole of collagen (mole/ mole(Pro + Hyp)/669); standard deviations in brackets.
| sample | HLNL | DHLNL | LNL | PYD | DPD | Pre-existing glucose-glycated Lys | Pre-existing glucose-glycated Hyl |
|---|---|---|---|---|---|---|---|
| Unglycated | 1.06 (0.07) | 0.140 (0.002) | 0.025 (0.002) | 0.65 (0.04) | — | 0.47 (0.02) | 0.15 (0.01) |
| R5P (50 mM) glycated | 0.4 (0.1) | 0.09 (0.07) | 0.07 (0.04) | 0.38 (0.15) | 0.11 (0.04) | 0.17 (0.05) | 0.11 (0.02) |
DPD levels in unglycated collagen were too low for measurement. (HLNL = hydroxylysinonorleucine; DHLNL = dihydroxylysinonorleucine; LNL = lysinonorleucine; PYD = pyridinoline; DPD = deoxypyridinoline).
Figure 2(A,B): Bright-field (BF) TEM of positively-stained (uranyl acetate) collagen fibrils. (A) Comparison of TEM images of glycated (top) and unglycated (bottom) collagen fibrils. The differences in overall image brightness between glycated and unglycated are arbitrary and used here to distinguish the images of the glycated/ unglycated fibrils. The sub-bands for one fibril D-period are labelled[44] for the same fibril D-period definition as in Fig. 1. The white rectangle indicates the typical region size over which the densitometry plots in B are calculated. (B) Densitometry plots (image intensity profiles) for representative D-periods for glycated and unglycated collagen fibril images, examples of which are shown in (A). The expected positions of the sub-bands for unglycated fibrils are indicated. (C,D): Bright-field (BF) TEM images of negatively-stained (uranyl acetate) collagen fibrils, equivalent to those in (A,B). In (D), the densitometry plots for unglycated collagen are from randomly selected D-periods on a single collagen fibril; plots are highly similar for all unreacted fibrils examined. Those for the glycated collagen are from the glycated collagen fibrils in (E) for a single D-period (as exemplified by the white rectangle). The uppermost densitometry plots for glycated collagen fibrils in (D) (blue and green) are from thicker fibrils (top two fibril images in (E) and the bottom two densitometry plots (yellow and brown) are from thinner fibrils (bottom two fibril images in (E). Dotted lines in densitometry plots in B and D indicate where relative image intensity is significantly reduced for glycated fibrils compared to unglycated fibrils. Scale bars in (E) are 100 nm.
Figure 3(A,B) Video camera images of a region of the HOPG sample with a collagen fibril before (A) and after (B) R5P treatment. (C,D) Representative AFM topography height images of collagen fibril number 2 from (A,B). Unglycated (C) and R5P-glycated (D) fibril section. (E,F) show longitudinal height profiles of dashed lines in (C,D), respectively. (G,H) Representative KFM surface potential maps of collagen fibril number 2 from (A,B). Unglycated (G) and R5P-glycated (H) fibril section. (J,K) show longitudinal potential profiles of dashed lines in (G,H), respectively. Surface potential values are with respect to surrounding HOPG as base level. Images and profiles (C,E,G,J) are on identical location of fibril. Images and profiles (D,F,H,K) are on identical location of fibril but different location from (C,E,G,J). (L) Effect of glycation on surface potential of overlap and gap zones of individually identified collagen fibrils (N = 11) measured by KFM. For each fibril, the overlap and gap zone surface potential reduction after R5P incubation is shown.
Autofluorescence decay data analysis by the FLIMfit software tool[74] glycated and unreacted control collagen before and after quenching with triiodide.
| Collagen | Collagen + I3− | Glycated collagen | Glycated collagen + I3− | |
|---|---|---|---|---|
| τ1/ns | 5.41 ± 0.22 | 3.59 ± 2.92* | 3.37 ± 0.25 | 3.7 ± 0.27 |
| τ2/ps | 670 ± 30 | 240 ± 15 | 510 ± 35 | 440 ± 25 |
| β1 | 0.28 ± 0.01 | 0.01 ± 0.01 | 0.20 ± 0.02 | 0.13 ± 0.02 |
| β2 | 0.72 ± 0.01 | 0.99 ± 0.01 | 0.80 ± 0.02 | 0.87 ± 0.02 |
Pre-exponential coefficients (β1 and β2) and fluorescence lifetime values (τ1 and τ2) are described by the decay law . Data is presented as mean of 6–9 independent samples ± SD. Differences between τ1, τ2, β1, β2 and mean τ were found statistically significant in paired t-test for each of the four experimental conditions (except *). See also Fig. S3.
HPLC gradient table.
| Time/min | % solvent A | % Solvent B | % Solvent C | Flow/ml/min | Curve |
|---|---|---|---|---|---|
| 0 | 100 | 0 | 0 | 0.4 | 1 |
| 5 | 60 | 40 | 0 | 0.4 | 6 |
| 7 | 10 | 90 | 0 | 0.4 | 6 |
| 9 | 0 | 0 | 100 | 0.4 | 1 |
| 11 | 0 | 0 | 100 | 0.4 | 1 |
| 12 | 100 | 0 | 0 | 0.4 | 1 |
| 20 | 100 | 0 | 0 | 0.4 | 1 |
System: Waters Alliance 2795.
Solvent A: (95% acetonitrile, 5% water) 0.1% formic acid, 0.005% Trifluoroacetic acid.
Solvent B: (20% methanol, 80% water), 0.1% formic acid.
Solvent C: water, 0.1% formic acid.
Curve 6 is a linear gradient, Curve 1 is a step change to the indicated percentage solvent.
MRM transitions and collision energy settings for collagen amino acids and crosslink components.
| Molecule | Q1 | Q2 | Collision energy | dwell/s |
|---|---|---|---|---|
| Proline (PRO) | 116.07 | 70.06 | 15 | 0.25 |
| d7-PRO | 123.11 | 77.11 | 15 | 0.25 |
| Hydroxyproline (HYP) | 132.06 | 68.05 | 20 | 0.25 |
| Lysine (Lys) | 147.11 | 84.08 | 20 | 0.25 |
| d4-LYS | 151.14 | 88.1 | 20 | 0.25 |
| Hydroxylysine (Hly) | 163.1 | 82.06 | 20 | 0.25 |
| LNL | 276.15 | 84.08 | 30 | 0.2 |
| HLNL | 292.18 | 82.08 | 30 | 0.2 |
| DHLNL | 308.18 | 82.08 | 35 | 0.2 |
| pentosidine | 379.21 | 187.1 | 40 | 0.2 |
| deoxypyridinoline | 413.2 | 84.08 | 40 | 0.3 |
| pyridinoline | 429.2 | 82.08 | 40 | 0.3 |